Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Why This Penny-Cap Diagnostics Stock Surged 10% After Advancing Ebola PCR Strategy?

Co-Diagnostics, Inc. (Nasdaq: CODX) shares surged more than 10% in pre-market trading on Thursday after the molecular diagnostics company announced progress in its PCR assay development strategy targeting the Bundibugyo virus (BDBV), an ebolavirus strain currently linked to outbreaks in the Democratic Republic of …

Nitish Kishor | 28 May 2026

Dow, S&P 500 and Nasdaq Hit Record Highs as Oil Slides on US-Iran Optimism

Indices Closing Summary (May 27, 2026):U.S. markets closed at or near record highs on Wednesday, May 27, supported by easing oil prices amid optimism around U.S.-Iran negotiations. TheDow Jones Industrial Averagefinished at 50,644.28, up 182.60 points or 0.36 percent for a fresh record close. …

Team Kalkine | 28 May 2026

US Durable Goods Orders Surge 7.9% in April, More Than Doubling Market Forecasts

April delivered the sharpest monthly jump in US durable goods orders in nearly a year. New orders for manufactured durable goods rose 7.9% to $346 billion, according to the U.S. Census Bureau's advance report released May 28, 2026, beating market forecasts of a 3.5% …

Nitish Kishor | 28 May 2026

GLP-1 Price War Intensifies as CVS Caremark Restores Zepbound, Adds Lilly's Oral Obesity Pill

CVS Health (NYSE:CVS) announced on Thursday that its pharmacy benefits arm, CVS Caremark, will expand coverage of GLP-1 weight management therapies by reinstating Eli Lilly's (NYSE:LLY) Zepbound injection and adding Foundayo, the company's newly approved oral obesity pill. The announcement marks a significant strategic …

Nitish Kishor | 28 May 2026